Literature DB >> 2121678

Antitumor effect of liposome-entrapped adriamycin administered via the portal vein.

T Ichino1, T Yotsuyanagi, I Mizuno, Y Akamo, T Yamamoto, T Saito, S Kurahashi, N Tanimoto, J Yura.   

Abstract

We examined the distribution in tissues and antitumor effect of freeze-dried liposome-entrapped adriamycin (Lipo-ADM) administered via the portal vein to rabbits bearing VX2 tumors. Liposomes composed of egg phosphatidylcholine (cholesterol 50 mol%) were used as drug carriers. The liver concentration of ADM increased after delivery and cardiac uptake decreased compared with free drug treatment. The in vivo antitumor effect of Lipo-ADM was determined in rabbits inoculated with VX2 tumor. Repeated injections of free ADM via the portal vein prolonged the life span of tumor-bearing rabbits. The life span was further prolonged by Lipo-ADM treatment compared with the control group and the free ADM group. Histological examination revealed that the damage to the liver caused by Lipo-ADM administered via the portal vein did not differ from that observed in animals treated with free ADM. These results indicate that portal vein administration of Lipo-ADM may be more effective in dealing with liver metastases than treatment with free ADM and may be therapeutically useful without toxic side effects.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2121678      PMCID: PMC5917974          DOI: 10.1111/j.1349-7006.1990.tb03345.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  27 in total

1.  Multivesicular liposomes containing 1-beta-D-arabinofuranosylcytosine for slow-release intrathecal therapy.

Authors:  S Kim; D J Kim; M A Geyer; S B Howell
Journal:  Cancer Res       Date:  1987-08-01       Impact factor: 12.701

2.  The blood supply of experimental liver metastases. IV. Changes in vascularity with increasing tumor growth.

Authors:  N B Ackerman
Journal:  Surgery       Date:  1974-04       Impact factor: 3.982

3.  Liposomal protection of adriamycin-induced cardiotoxicity in mice.

Authors:  A Rahman; A Kessler; N More; B Sikic; G Rowden; P Woolley; P S Schein
Journal:  Cancer Res       Date:  1980-05       Impact factor: 12.701

4.  Liposomes as in vivo carriers of adriamycin: reduced cardiac uptake and preserved antitumor activity in mice.

Authors:  A Gabizon; A Dagan; D Goren; Y Barenholz; Z Fuks
Journal:  Cancer Res       Date:  1982-11       Impact factor: 12.701

5.  Toxicity of non-drug-containing liposomes for cultured human cells.

Authors:  E Mayhew; M Ito; R Lazo
Journal:  Exp Cell Res       Date:  1987-07       Impact factor: 3.905

6.  Doxorubicin-induced chronic cardiotoxicity and its protection by liposomal administration.

Authors:  A Rahman; N More; P S Schein
Journal:  Cancer Res       Date:  1982-05       Impact factor: 12.701

7.  "In vivo" distribution of liposomes between parenchymal and non parenchymal cells in rat liver.

Authors:  J Freise; W H Müller; C Brölsch; F W Schmidt
Journal:  Biomedicine       Date:  1980-10

8.  Enhancement of adriamycin delivery to liver metastatic cells with increased tumoricidal effect using liposomes as drug carriers.

Authors:  A Gabizon; D Goren; Z Fuks; Y Barenholz; A Dagan; A Meshorer
Journal:  Cancer Res       Date:  1983-10       Impact factor: 12.701

9.  Alterations in murine host defense functions by adriamycin or liposome-encapsulated adriamycin.

Authors:  K Mace; E Mayhew; E Mihich; M J Ehrke
Journal:  Cancer Res       Date:  1988-01-01       Impact factor: 12.701

10.  Differential patterns of vasculature to liver tumours.

Authors:  J Assa
Journal:  Br J Cancer       Date:  1970-06       Impact factor: 7.640

View more
  2 in total

1.  Implementing Central Composite Design for Developing Transdermal Diacerein-Loaded Niosomes: Ex vivo Permeation and In vivo Deposition.

Authors:  Diana Edwar Aziz; Aly Ahmed Abdelbary; Abdelhalim Ibrahim Elassasy
Journal:  Curr Drug Deliv       Date:  2018       Impact factor: 2.565

2.  Delivery of lymph node-targeted adriamycin by gastric submucosal liposomal injection in rabbits.

Authors:  Y Akamo; T Yotsuyanagi; I Mizuno; T Ichino; N Tanimoto; S Kurahashi; T Saito; T Yamamoto; T Yasui; Y Itabashi
Journal:  Jpn J Cancer Res       Date:  1993-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.